Solventum (SOLV) Net Income towards Common Stockholders (2023 - 2026)

Solventum (SOLV) posted Net Income towards Common Stockholders of $13.0 million for Q1 2026, down 79.37% on a QoQ basis from $63.0 million in Q4 2025, and down 90.51% year-over-year from $137.0 million in Q1 2025.

Solventum (SOLV) Net Income towards Common Stockholders (2023 - 2026) Analysis & Trends

Solventum's Net Income towards Common Stockholders history runs 4 years deep, the most recent figure standing at $13.0 million for Q1 2026.

  • Quarterly Net Income towards Common Stockholders fell 90.51% year-over-year to $13.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 billion (up 278.84% YoY) and the FY2025 annual result came in at $1.6 billion, up 225.52% from the prior year.
  • Net Income towards Common Stockholders was $13.0 million for Q1 2026 at Solventum, down from $63.0 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $1.3 billion in Q3 2025 and bottomed at $13.0 million in Q1 2026.
  • A 4-year average of $261.0 million and a median of $137.0 million in 2025 frame the typical range for Net Income towards Common Stockholders.
  • Annual changes were most pronounced in 2025 — Net Income towards Common Stockholders soared 937.7% — and 2026, when it tumbled 90.51%.
  • Solventum's Net Income towards Common Stockholders stood at $272.0 million in 2023, then sank by 88.97% to $30.0 million in 2024, then surged by 110.0% to $63.0 million in 2025, then sank by 79.37% to $13.0 million in 2026.
  • Business Quant data shows SOLV's Net Income towards Common Stockholders at $13.0 million in Q1 2026, $63.0 million in Q4 2025, and $1.3 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Alcon 33,163,703.85 Bn 33,163,702.19 Bn 1.53 Bn 22.13 Bn
2 Intuitive Surgical 119.67 Bn 114.45 Bn 1.96 Bn 823.20 Mn
3 Becton Dickinson 43.92 Bn 43.11 Bn 2.15 Bn -274.00 Mn
4 Medline 31.71 Bn 29.47 Bn 1.84 Bn 239.00 Mn
5 Resmed 28.46 Bn 26.80 Bn 890.98 Mn 398.73 Mn
6 West Pharmaceutical Services 23.80 Bn 23.28 Bn 296.40 Mn 135.40 Mn
7 Cooper Companies 13.77 Bn 13.63 Bn 735.40 Mn -77.90 Mn
8 Solventum 13.63 Bn 13.06 Bn 1.10 Bn 13.00 Mn
9 Align Technology 11.94 Bn 10.88 Bn 736.59 Mn 112.77 Mn
10 Baxter International 11.56 Bn 9.54 Bn 891.00 Mn 2.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 13.00 Mn
Dec 31, 2025 63.00 Mn
Sep 30, 2025 1.27 Bn
Jun 30, 2025 90.00 Mn
Mar 31, 2025 137.00 Mn
Dec 31, 2024 30.00 Mn
Sep 30, 2024 122.00 Mn
Jun 30, 2024 89.00 Mn
Mar 31, 2024 237.00 Mn
Dec 31, 2023 272.00 Mn
Sep 30, 2023 460.00 Mn
Jun 30, 2023 321.00 Mn
Mar 31, 2023 293.00 Mn